Lyme Arthritis Clinical Trial
— ArthLymeOfficial title:
Characteristics of Positive Lyme PCR Arthritis, Data From CNR Borrelia 2011-2016
Lyme disease is due to Borrelia burgdorferi sensu lato and is transmitted by a tick vector of the genus Ixodes. One of the clinical forms of this disease in the disseminated phase is the appearance of arthritis, classically mono or oligo-arthritis in the large joints.
| Status | Recruiting |
| Enrollment | 38 |
| Est. completion date | January 2019 |
| Est. primary completion date | January 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Age >18 years - Diagnosis of Lyme arthritis confirmed by PCR of joint fluid at CNR Borrelia between 2011 and 2016 - Patient who has agreed to use his medical data for research purposes Exclusion Criteria: - Refusal to participate in the study |
| Country | Name | City | State |
|---|---|---|---|
| France | Laboratoire de Bacteriologie - Ptm | Strasbourg |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Strasbourg, France |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Retrospective study of clinical and biological data of French patients with Lyme arthritis between 2011 and 2016 | The period from 2011 to 2016 will be examined |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04577053 -
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
|
N/A | |
| Recruiting |
NCT04038346 -
Symptomatic Management of Lyme Arthritis
|
Phase 3 | |
| Completed |
NCT03505879 -
Next Generation Sequencing Detection of Lyme Disease
|